Serum autoantibodies as biomarkers for early cancer detection
Top Cited Papers
- 16 November 2009
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 276 (23), 6880-6904
- https://doi.org/10.1111/j.1742-4658.2009.07396.x
Abstract
Autoantibodies against autologus tumor‐associated antigens have been detected in the asymptomatic stage of cancer and can thus serve as biomarkers for early cancer diagnosis. Moreover, because autoantibodies are found in sera, they can be screened easily using a noninvasive approach. Consequently, many studies have been initiated to identify novel autoantibodies relevant to various cancer types. To facilitate autoantibody discovery, approaches that allow the simultaneous identification of multiple autoantibodies are preferred. Five such techniques – SEREX, phage display, protein microarray, SERPA and MAPPing – are discussed here. In the second part of this review, we discussed autoantibodies found in the five most common cancers (lung, breast, colorectal, stomach and liver). The discovery of panels of tumor‐associated antigens and autoantibody signatures with high sensitivity and specificity would aid in the development of diagnostics, prognostics and therapeutics for cancer patients.Keywords
This publication has 162 references indexed in Scilit:
- Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassayJournal of Immunological Methods, 2009
- Detection of tumor-specific autoantibodies in sera of patients with lung cancerLung Cancer, 2008
- Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinomaJournal of Hepatology, 2007
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patientsGastric Cancer, 2005
- Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancerBiochemical and Biophysical Research Communications, 2005
- Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinomaEuropean Journal of Cancer, 2004
- The Global Burden of Chronic DiseasesJama-Journal Of The American Medical Association, 2004
- Diversity of antinucelar antibody responses in hepatocellular carcinomaJournal of Hepatology, 1997
- Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumoursEuropean Journal of Cancer, 1996